首页> 外文期刊>Chemical and Pharmaceutical Bulletin >Studies on Quinolone Antibacterials. IV. Structure-Activity Relationships of Antibacterial Activity and Side Effects for 5- or 8-Substituted and 5,8-Disubstituted-7-(3-amino-l-pyrrolidinyl)-l-cyclopropyl-l,4-dihydro-4-oxoquinoline-3-carboxylic Acids
【24h】

Studies on Quinolone Antibacterials. IV. Structure-Activity Relationships of Antibacterial Activity and Side Effects for 5- or 8-Substituted and 5,8-Disubstituted-7-(3-amino-l-pyrrolidinyl)-l-cyclopropyl-l,4-dihydro-4-oxoquinoline-3-carboxylic Acids

机译:喹诺酮类抗菌药的研究。 IV。 5-或8-取代的5,8-二取代-7-(3-氨基-1-吡咯烷基)-1-环丙基-1,4-二氢-4-氧代喹啉-的抗菌活性与活性和副作用的结构-活性关系3-羧酸

获取原文
获取原文并翻译 | 示例
           

摘要

A series of 7-(3-amino-l-pyrrolidinyl)-l-cyclopropyI-l,4-dihydro-4-oxoquinoline-3-carboxylic acids bearing various substituents (H, F, Cl, Me, OH, OMe, OEt, OCH2F, OCHF2, OCF3, SMe) at the C-8 position was prepared and evaluated for in vitro antibacterial activity against both standard laboratory strains and bacteria resistant to quinolones such as ciprofloxacin (CPFX, 1) and ofloxacin (OFLX, 2) from clinical isolates. The 8-methyl (8a), 8-fluoro (9a), 8-chloro (10a) and 8-methoxy (12a) compounds were 4 times more potent than CPFX (1) against both gram-positive and gram-negative bacteria. But these four compounds caused injury to the chromosomes of mammalian cells at a concentration of 100/ig/ml. Next, a series of quinolones having various substituents (H, Cl, Me, NH2, NHMe, NMe2) at the C-5 position was prepared and evaluated for antibacterial activity and injurious eifect on the chromosome. We found that the 5-amino-8-methyl compound (8d) showed strong antibacterial activity (in vitro antibacterial activity of 8d is 4 times more potent than that of CPFX (1) against both gram-positive and gram-negative bacteria), reduced injury to the chromosome, and reduced quinolonc-typc toxicity (free from both phototoxicity at a dosage of 30mg/kg in guinea pigs (i.v.) and convulsion-inducing activity when coadministercd with fenbufen at a dosage of 100 mg/kg in mice (i.p.)).
机译:一系列带有各种取代基(H,F,Cl,Me,OH,OMe,OEt的7-(3-氨基-1-吡咯烷基)-1-环丙基I-1,4-二氢-4-氧代喹啉-3-羧酸制备了C-8位置的OCH2F,OCHF2,OCF3,SMe),并评估了其对标准实验室菌株以及对喹诺酮类耐药的细菌的体外抗菌活性,如环丙沙星(CPFX,1)和氧氟沙星(OFLX,2)临床分离株。对于革兰氏阳性和革兰氏阴性细菌,8-甲基(8a),8-氟(9a),8-氯(10a)和8-甲氧基(12a)化合物的效力是CPFX(1)的4​​倍。但是这四种化合物以100 / ig / ml的浓度对哺乳动物细胞的染色体造成了伤害。接下来,制备在C-5位置具有各种取代基(H,Cl,Me,NH 2,NHMe,NMe 2)的一系列喹诺酮,并评估其对染色体的抗菌活性和有害作用。我们发现5-氨基-8-甲基化合物(8d)具有很强的抗菌活性(8d的体外抗菌活性是CPFX(1)对革兰氏阳性和革兰氏阴性细菌的4倍),减少了对染色体的伤害,并减少了喹诺酮型毒性(在豚鼠中以30mg / kg的剂量(iv)既无光毒性,又在小鼠中以100mg / kg的剂量与fenbufen共同施用时具有惊厥诱导活性( ip))。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号